Compare Abeona Therapeutics Inc (ABEO) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Tilray Brands Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Tilray Brands Inc trades at $4.78 (market cap $649.42M). The key difference: Tilray Brands Inc is the larger of the two by market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | TLRY | |
|---|---|---|
Market Cap | $421.19M | $649.42M |
Sector | Health | Health |
52-Week High | $7.45 | $21.00 |
52-Week Low | $4.17 | $3.88 |
Enterprise Value | $276.10M | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
